ETFs Holding ZIOP »    ZIOP Historical Stock Prices »
ZIOP News Video: Tue, Aug 22, 2017, 3:11 PM — Tuesday's ETF Movers: XBI, GDXJ

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ZIOPHARM Oncology is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing immunotherapy platforms that employ gene- and cell-based therapies to treat patients with cancer. Co. is developing two immuno-oncology platform technologies designed to utilize the patient's immune system by employing controlled gene expression and cell engineering technologies for the treatment of multiple cancer types. Co. is developing two platform technologies which it uses in the implementation of its product candidates: Controlled IL-12, which delivers interleukin 12 or IL-12; and Sleeping Beauty platforms for the treatment of oncology indications. Self directed investors in ZIOPHARM Oncology Inc will be interested in keeping up with all ZIOPHARM Oncology Inc news they can find, both ZIOP news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ZIOP. At RediNews, we simplify this task by presenting both ZIOP news releases originating from ZIOPHARM Oncology Inc itself, and ZIOP news from a variety of media outlets. Visitors can browse this news online and through our ZIOP RSS news feed.


ZIOP News — Articles, Videos, & Press Releases

Intrexon (XON) Reports Narrower-Than-Expected Loss in Q4
Friday, March 1, 2019, 8:16 AM — Zacks
How The Pieces Add Up: KOMP Headed For $36
Wednesday, February 6, 2019, 7:48 AM — ETF Channel
Interesting ZIOP Put And Call Options For March 15th
Thursday, January 24, 2019, 11:29 AM — Stock Options Channel
First Week of ZIOP February 15th Options Trading
Thursday, January 3, 2019, 11:34 AM — Stock Options Channel
Implied IEIH Analyst Target Price: $31
Thursday, January 3, 2019, 7:41 AM — ETF Channel
Analysts Expect 25% Upside For IEIH
Wednesday, November 28, 2018, 7:23 AM — ETF Channel
First Week of ZIOP July 2019 Options Trading
Wednesday, November 21, 2018, 11:23 AM — Stock Options Channel
The Implied Analyst 12-Month Target For ESML
Monday, October 15, 2018, 8:08 AM — ETF Channel
First Week of ZIOP November 16th Options Trading
Wednesday, September 26, 2018, 11:22 AM — Stock Options Channel
Interesting ZIOP Put And Call Options For January 2021
Tuesday, September 18, 2018, 11:16 AM — Stock Options Channel
We Did The Math IEIH Can Go To $31
Monday, August 27, 2018, 7:42 AM — ETF Channel
Interesting ZIOP Put And Call Options For April 2019
Wednesday, August 22, 2018, 10:46 AM — Stock Options Channel
First Week of ZIOP September 21st Options Trading
Wednesday, July 25, 2018, 11:16 AM — Stock Options Channel
Peek Under The Hood: IEIH Has 16% Upside
Tuesday, July 24, 2018, 7:35 AM — ETF Channel
Look Under The Hood: XBI Has 33% Upside
Thursday, June 21, 2018, 8:12 AM — ETF Channel
ZIOPHARM Oncology Breaks Above 200-Day Moving Average - Bullish for ZIOP
Wednesday, May 30, 2018, 11:57 AM — Market News Video
ZIOP is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

KIN News

If you use web portal software to control your web site content, chances are your portal software already makes it easy for you to integrate RSS feeds from third party sources, like RediNews. Using RSS — short for Really Simple Syndication — makes content syndication a snap, so even if you have never worked with a stock data feed before, you should still have no problem working with the content delivery mechanism made possible by RSS. These RediNews RSS feeds are found throughout our website wherever news is found, whether by sector or custom content by symbol, by clicking the RSS icon for any news page (which will look like this): .

ZIOP News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.